{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:45:20Z","timestamp":1789332320755,"version":"build-2803163510"},"reference-count":239,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","brainanddevelopment.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.braindev.2024.104306","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:11:36Z","timestamp":1733141496000},"page":"104306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Japanese guidelines for treatment of pediatric status epilepticus \u2013 2023"],"prefix":"10.1016","volume":"47","author":[{"given":"Kenjiro","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Shiohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitami","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Maegaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.104306_bb0005","series-title":"Research committee on clinical evidence of medical treatment for status epilepticus in childhood","author":"Osawa","year":"2005"},{"key":"10.1016\/j.braindev.2024.104306_bb0010","series-title":"Committee for the compilation of Guideline for the treatment of status epilepticus in childhood. Guideline for the treatment of status epilepticus in childhood 2017","year":"2017"},{"key":"10.1016\/j.braindev.2024.104306_bb0015","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus-report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0020","first-page":"1226","article-title":"Need for a pediatric emergency system for status epilepticus in Saitama prefecture","volume":"119","author":"Kikuchi","year":"2015","journal-title":"J Jpn Pediatr Soc (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0025","first-page":"12","article-title":"Is a doctor car effective for children with convulsive status epilepticus?","volume":"16","author":"Nozawa","year":"2017","journal-title":"J Jpn Soc Emer Pediatr (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.seizure.2015.04.002","article-title":"Admissions to paediatric intensive care units (PICU) with refractory convulsive status epilepticus (RCSE): a two-year multi-Centre study","volume":"29","author":"Tully","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clineuro.2014.07.038","article-title":"Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit","volume":"126","author":"Vooturi","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.braindev.2024.104306_bb0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejpn.2015.05.007","article-title":"Etiology, clinical course and response to the treatment of status epilepticus in children: a 16-year single-center experience based on 602 episodes of status epilepticus","volume":"19","author":"Kravljanac","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.seizure.2010.10.034","article-title":"Convulsive status epilepticus in children: etiology, treatment protocol and outcome","volume":"20","author":"Saz","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1528-1167.2007.01465.x","article-title":"Aborted and refractory status epilepticus in children: a comparative analysis","volume":"49","author":"Lambrechtsen","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0060","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/01.WNL.0000073139.53008.F2","article-title":"Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children","volume":"61","author":"Sahin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0070","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1046\/j.1528-1157.2001.21301.x","article-title":"Outcome of severe refractory status epilepticus in children","volume":"42","author":"Sahin","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12028-018-0513-0","article-title":"Outcomes in children treated with pentobarbital infusion for refractory and super-refractory status epilepticus","volume":"29","author":"Erklauer","year":"2018","journal-title":"Neurocrit Care"},{"issue":"Suppl. 8","key":"10.1016\/j.braindev.2024.104306_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2011.03238.x","article-title":"Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation","volume":"52","author":"Shorvon","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0085","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2024.104306_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1535759721999670","article-title":"Treatment of super-refractory status epilepticus: a review","volume":"21","author":"Ochoa","year":"2021","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.braindev.2024.104306_bb0095","doi-asserted-by":"crossref","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"Alkhachroum","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0100","doi-asserted-by":"crossref","first-page":"e2339","DOI":"10.1212\/WNL.0000000000007503","article-title":"Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus","volume":"92","author":"S\u00e1nchez Fern\u00e1ndez","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"NLSTEPSS collaborative group. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","article-title":"Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR)","volume":"55","author":"Coeytaux","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.50.3.735","article-title":"Incidence of status epilepticus in Rochester, Minnesota, 1965\u20131984","volume":"50","author":"Hesdorffer","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0120","first-page":"1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Virginia Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0130","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1212\/WNL.58.7.1070","article-title":"Incidence and mortality of generalized convulsive status epilepticus in California","volume":"58","author":"Wu","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0135","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/dmcn.14900","article-title":"Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study","volume":"63","author":"Mitchell","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2011.05.004","article-title":"An epidemiological study of children with status epilepticus in Okayama, Japan: incidence, etiologies, and outcomes","volume":"96","author":"Nishiyama","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb0145","first-page":"1336","article-title":"Epidemiology of status epilepticus in childhood","volume":"118","author":"Moriyama","year":"2014","journal-title":"J Jpn Pediatr Soc (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/WNP.0000000000000657","article-title":"Status epilepticus in children","volume":"37","author":"Zimmern","year":"2020","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.braindev.2024.104306_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.04.039","article-title":"The outcomes of childhood convulsive status epilepticus","volume":"101","author":"Chin","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","article-title":"Treatment of refractory status epilepticus: literature review and a proposed protocol","volume":"38","author":"Abend","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/PCC.0000000000002108","article-title":"New-onset refractory status epilepticus in children: etiologies, treatments, and outcomes","volume":"21","author":"Husari","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"Suppl","key":"10.1016\/j.braindev.2024.104306_bb0175","first-page":"S12","article-title":"Status epilepticus: refractory and super-refractory","volume":"65","author":"Dubey","year":"2017","journal-title":"Neurol India"},{"key":"10.1016\/j.braindev.2024.104306_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-015-0589-2","article-title":"Treatment of super-refractory status epilepticus","volume":"15","author":"Bayrlee","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.braindev.2024.104306_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ane.12605","article-title":"Refractory and super-refractory status epilepticus in adults: a 9-year cohort study","volume":"135","author":"Delaj","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2024.104306_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ane.12336","article-title":"Super-refractory status epilepticus in West China","volume":"132","author":"Tian","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2024.104306_bb0195","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2015.04.065","article-title":"Incidence and mortality of super-refractory status epilepticus in adults","volume":"49","author":"Kantanen","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107929","article-title":"Predictors of outcome in super refractory status epilepticus","volume":"118","author":"Jose","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yebeh.2018.06.029","article-title":"The etiology and prognosis of super-refractory convulsive status epilepticus in children","volume":"86","author":"Lu","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0210","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1097\/PCC.0000000000002786","article-title":"Super-refractory status epilepticus in children: a retrospective cohort study","volume":"22","author":"Vasquez","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0215","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1469-8749.1997.tb07358.x","article-title":"Status epilepticus in children: aetiology, treatment, and outcome","volume":"39","author":"Eriksson","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0220","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1528-1167.2007.01175.x","article-title":"The epidemiology of convulsive status epilepticus in children: a critical review","volume":"48","author":"Raspall-Chaure","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PEC.0b013e318196ea6e","article-title":"Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients","volume":"25","author":"Lewena","year":"2009","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.braindev.2024.104306_bb0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5144\/0256-4947.2017.455","article-title":"Retrospective review of pediatric status epilepticus in 116 Saudi patients: predictors of outcome","volume":"37","author":"Hommady","year":"2017","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.seizure.2020.04.001","article-title":"Clinical characteristics and prognosis in a large paediatric cohort with status epilepticus","volume":"80","author":"Wang","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0240","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/epi.16385","article-title":"Pediatric status epilepticus: identification of prognostic factors using the new ILAE classification after 5 years of follow-up","volume":"60","author":"Specchio","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.seizure.2020.03.019","article-title":"Clinical characterization of status epilepticus in childhood: a retrospective study in 124 patients","volume":"78","author":"Chiarello","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0250","doi-asserted-by":"crossref","first-page":"26","DOI":"10.17712\/nsj.2021.1.20200116","article-title":"The etiology and risk factors of convulsive status epilepticus in pediatric patients of tertiary center in Saudi Arabia","volume":"26","author":"Alyoubi","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"key":"10.1016\/j.braindev.2024.104306_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.seizure.2019.06.011","article-title":"The effect of early midazolam infusion on the duration of pediatric status epilepticus patients","volume":"71","author":"Ulusoy","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0260","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-2005-865611","article-title":"Risk factors for fatality and neurological sequelae after status epilepticus in children","volume":"36","author":"Maegaki","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.braindev.2024.104306_bb0265","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pediatrneurol.2007.02.012","article-title":"Efficacy of intravenous midazolam for status epilepticus in childhood","volume":"36","author":"Hayashi","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0270","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.braindev.2008.02.003","article-title":"Underlying neurologic disorders and recurrence rates of status epilepticus in childhood","volume":"30","author":"Okanishi","year":"2008","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0275","first-page":"395","article-title":"Choice and administration sequence of antiepileptic agents for status epilepticus and frequent seizures in children","volume":"37","author":"Hamano","year":"2005","journal-title":"No To Hattatsu (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0280","first-page":"956","article-title":"Clinical study of status epilepticus in children","volume":"114","author":"Shiohama","year":"2010","journal-title":"J Jpn Pediatr Soc (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0285","first-page":"687","article-title":"Choice and efficacy of intravenous antiepileptic drugs for status epilepticus in children","volume":"116","author":"Kikuchi","year":"2012","journal-title":"J Jpn Pediatr Soc (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0290","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2018.09.035","article-title":"Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus","volume":"396","author":"Hamano","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2024.104306_bb0295","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.seizure.2018.08.021","article-title":"The burden of pediatric status epilepticus: epidemiology, morbidity, mortality, and costs","volume":"68","author":"Gurcharran","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0300","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1474-4422(06)70546-4","article-title":"Outcome of paediatric convulsive status epilepticus: a systematic review","volume":"5","author":"Raspall-Chaure","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0305","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.braindev.2014.08.004","article-title":"Status epilepticus study group. Early predictors of status epilepticus-associated mortality and morbidity in children","volume":"37","author":"Maegaki","year":"2015","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pediatrneurol.2015.02.001","article-title":"Demographics and outcomes of patients with pediatric febrile convulsive status epilepticus","volume":"52","author":"Nishiyama","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0315","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1542\/peds.83.3.323","article-title":"Low morbidity, and mortality of status epilepticus in children","volume":"83","author":"Maytal","year":"1989","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2024.104306_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneur.1973.00490190019001","article-title":"Physiology of status epilepticus in primates","volume":"28","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0325","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archneur.1973.00490190028002","article-title":"Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events","volume":"28","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0330","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.1973.00490260026003","article-title":"Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons","volume":"29","author":"Meldrum","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.seizure.2018.08.002","article-title":"Pathophysiology of convulsive status epilepticus","volume":"68","author":"S\u00e1nchez Fern\u00e1ndez","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0340","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci"},{"issue":"Suppl. 5","key":"10.1016\/j.braindev.2024.104306_bb0345","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1528-1167.2007.01297.x","article-title":"GABA(a) receptor internalization during seizures","volume":"48","author":"Goodkin","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0350","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(a) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.braindev.2024.104306_bb0355","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.braindev.2024.104306_bb0360","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ana.23570","article-title":"Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus","volume":"72","author":"Rajasekaran","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0365","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.25635","article-title":"\u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor plasticity sustains severe, fetal status epilepticus","volume":"87","author":"Adotevi","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0370","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/brain\/awz283","article-title":"Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus","volume":"142","author":"Burman","year":"2019","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/j.braindev.2024.104306_bb0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/epi4.12271","article-title":"Treatment of early life status epilepticus: what can we learn from animal models?","volume":"3","author":"Thompson","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.braindev.2024.104306_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.06.011","article-title":"Early polytherapy for benzodiazepine-refractory status epilepticus","volume":"101","author":"Niquet","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0385","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934043","article-title":"Diazepam monotherapy or diazepam-ketamine dual therapy at different time points terminates seizures and reduces mortality in a status epilepticus animal model","volume":"27","author":"Zhou","year":"2021","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.braindev.2024.104306_bb0390","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/epi4.12552","article-title":"Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats","volume":"6","author":"Lumley","year":"2021","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.braindev.2024.104306_bb0395","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"issue":"Suppl. 7","key":"10.1016\/j.braindev.2024.104306_bb0400","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/epi.12307","article-title":"Treatment of convulsive status epilepticus in childhood: recommendations of the Italian league against epilepsy","volume":"54","author":"Capovilla","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb0410","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"10.1016\/j.braindev.2024.104306_bb0415","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1440-1754.2009.01536.x","article-title":"Emergency management of paediatric status epilepticus in Australia and New Zealand: practice patterns in the context of clinical practice guidelines","volume":"45","author":"Babl","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.braindev.2024.104306_bb0420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/pch\/16.2.91","article-title":"Emergency management of the paediatric patient with generalized convulsive status epilepticus","volume":"16","author":"Friedman","year":"2011","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.braindev.2024.104306_bb0425","series-title":"Infants and Children: Acute Management of Seizures. 3rd ed","author":"Office of Kids and Families, Ministry of Health, NSW","year":"2016"},{"key":"10.1016\/j.braindev.2024.104306_bb0430","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","article-title":"Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb0435","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/PEC.0000000000001114","article-title":"Buccal midazolam compared with rectal diazepam reduces seizure duration in children in the outpatient setting","volume":"35","author":"Moretti","year":"2019","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.braindev.2024.104306_bb0440","first-page":"495","article-title":"The effectiveness of chloral hydrate rectal kits (ESCRE\u00ae rectal kits) for convulsive seizure in childhood -comparison with diazepam suppository (DIAPP\u00ae)","volume":"52","author":"Minagawa","year":"2011","journal-title":"Shonika (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0445","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1469-8749.1983.tb13800.x","article-title":"The use of chloral hydrate for refractory childhood epilepsy","volume":"25","author":"Powell","year":"1983","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0887-8994(01)00350-2","article-title":"Chloral hydrate for progressive myoclonus epilepsy: a new look at an old drug","volume":"25","author":"Pranzatelli","year":"2001","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0455","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0887-8994(02)00464-2","article-title":"Successful treatment of Ohtahara syndrome with chloral hydrate","volume":"27","author":"Krsek","year":"2002","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0460","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/adc.2002.019836","article-title":"Nasal\/buccal midazolam use in the community","volume":"89","author":"Wilson","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.braindev.2024.104306_bb0465","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.seizure.2008.12.002","article-title":"The community use of rescue medication for prolonged epileptic seizures in children","volume":"18","author":"Klimach","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0470","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1111\/apa.12529","article-title":"Carers\u2019 express positive views on the acceptability, efficacy and safety of buccal midazolam for paediatric status epilepticus","volume":"103","author":"Khan","year":"2014","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yebeh.2018.12.007","article-title":"A hospital-based study on caregiver preferences on acute seizure rescue medications in pediatric patients with epilepsy: intranasal midazolam versus rectal diazepam","volume":"92","author":"Nunley","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2020.01.005","article-title":"Dravet syndrome: a review of current management","volume":"107","author":"Wheless","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0485","article-title":"The unmet need for rapid epileptic seizure termination (REST)","volume":"15","author":"Asnis-Alibozek","year":"2020","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.braindev.2024.104306_bb0490","article-title":"Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children","volume":"1","author":"McTague","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.braindev.2024.104306_bb0495","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12098-011-0505-y","article-title":"Intravenous diazepam, midazolam and lorazepam in acute seizure control","volume":"79","author":"Gathwala","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0500","doi-asserted-by":"crossref","first-page":"e2683","DOI":"10.1212\/WNL.0000000000010828","article-title":"First-line medication dosing in pediatric refractory status epilepticus","volume":"95","author":"Vasquez","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0505","first-page":"484","article-title":"Eight-year study on the treatment with intravenous midazolam for status epilepticus and clusters of seizures in children","volume":"35","author":"Minagawa","year":"2003","journal-title":"No To Hattatsu (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0510","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0387-7604(00)00116-9","article-title":"Midazolam as a first-line agent for status epilepticus in children","volume":"22","author":"Yoshikawa","year":"2000","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0515","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.yebeh.2009.02.018","article-title":"Intravenous midazolam in convulsive status epilepticus in children with pharmacoresistant epilepsy","volume":"14","author":"Papavasiliou","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0520","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1001\/jama.2014.2625","article-title":"Pediatric emergency care applied research network (PECARN). Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial","volume":"311","author":"Chamberlain","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.braindev.2024.104306_bb0525","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1469-8749.1995.tb15014.x","article-title":"Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus","volume":"37","author":"Appleton","year":"1995","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0530","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1167.2010.02949.x","article-title":"Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study","volume":"52","author":"Arya","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0535","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpn.2009.02.004","article-title":"Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial","volume":"14","author":"Sreenath","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0540","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00415-012-6659-3","article-title":"A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures","volume":"260","author":"Thakker","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0545","first-page":"303","article-title":"A comparison of buccal midazolam and intravenous diazepam for the acute treatment of seizures in children","volume":"22","author":"Tonekaboni","year":"2012","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0550","first-page":"1","article-title":"Intranasal midazolam compared with intravenous diazepam in patients suffering from acute seizure: a randomized clinical trial","volume":"22","author":"Javadzadeh","year":"2012","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0555","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.braindev.2008.11.006","article-title":"Efficacy of buccal midazolam compared to intravenous diazepam in controlling convulsions in children: a randomized controlled trial","volume":"31","author":"Talukdar","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0560","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.321.7253.83","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study","volume":"321","author":"Lahat","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.braindev.2024.104306_bb0565","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.yebeh.2004.01.003","article-title":"Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children","volume":"5","author":"Mahmoudian","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106651","article-title":"A phase 3 open-label study of the efficacy, safety and pharmacokinetics of buccally administered midazolam hydrochloride for the treatment of status epilepticus in pediatric Japanese subjects","volume":"174","author":"Yoshinaga","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb0575","first-page":"283","article-title":"Intranasal midazolam for prevention of status epilepticus","volume":"33","author":"Fujita","year":"2001","journal-title":"No To Hattatsu (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0580","first-page":"34","article-title":"Study of an efficacy and a pharmacokinetics of intranasal midazolam for status epilepticus on childhood epilepsy","volume":"4","author":"Kuki","year":"2010","journal-title":"No To Hattatsu (Tokyo)"},{"key":"10.1016\/j.braindev.2024.104306_bb0585","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0887-8994(92)90071-6","article-title":"Midazolam in treatment of epileptic seizures","volume":"8","author":"Lahat","year":"1992","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0590","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)79574-X","article-title":"Intranasal midazolam for childhood seizures","volume":"352","author":"Lahat","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb0595","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2020.03.011","article-title":"Intramuscular versus buccal midazolam for pediatric seizures: a randomized double-blinded trial","volume":"109","author":"Alansari","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0600","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.yebeh.2015.02.030","article-title":"Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis","volume":"49","author":"Brigo","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0605","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.eplepsyres.2016.02.006","article-title":"Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: systematic review and meta-analysis","volume":"122","author":"Jain","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb0610","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.38.2.202","article-title":"Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin","volume":"38","author":"Shaner","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0615","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0620","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00415-011-6227-2","article-title":"Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study","volume":"259","author":"Misra","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0625","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yebeh.2014.06.008","article-title":"A retrospective observational study of current treatment for generalized convulsive status epilepticus","volume":"37","author":"Langer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0630","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.braindev.2024.104306_bb0635","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/epi.13716","article-title":"Lacosamide in status epilepticus: Systematic review of current evidence","volume":"58","author":"Strzelczyk","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0640","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pediatrneurol.2016.03.021","article-title":"Intravenous lacosamide in pediatric status epilepticus: an open-label efficacy and safety study","volume":"61","author":"Poddar","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0645","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2017.09.019","article-title":"Safety of intravenous lacosamide in critically ill children","volume":"52","author":"Welsh","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0650","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb0655","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"NETT and PECARN Investigators. Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0660","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"PREDICT research network. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb0665","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Paediatric Emergency Research in the United Kingdom & Ireland (PERUKI) collaborative. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb0670","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3345\/kjp.2016.59.1.35","article-title":"Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures","volume":"59","author":"Lee","year":"2016","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0675","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejpn.2012.01.012","article-title":"Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial","volume":"16","author":"Malamiri","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0680","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2010.01423.x","article-title":"Intravenous lacosamide for treatment of status epilepticus","volume":"123","author":"Kellinghaus","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2024.104306_bb0685","doi-asserted-by":"crossref","first-page":"106466","DOI":"10.1016\/j.yebeh.2019.106466","article-title":"Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: a systematic review and network meta-analysis","volume":"101","author":"Brigo","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0690","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S0317167100022769","article-title":"Anesthetic barbiturates in refractory status epilepticus","volume":"7","author":"Young","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.braindev.2024.104306_bb0695","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s13312-014-0543-4","article-title":"Multi-disciplinary Group on Management of Status Epilepticus in Children in India. Consensus guidelines on management of childhood convulsive status epilepticus","volume":"51","author":"Mishra","year":"2014","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0700","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/PCC.0000000000000900","article-title":"Pediatric Status Epilepticus Research Group. Refractory status epilepticus in children: intention to treat with continuous infusions of midazolam and pentobarbital","volume":"17","author":"Tasker","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0705","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pediatrneurol.2014.02.021","article-title":"Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus","volume":"51","author":"Nagase","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0710","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00415-016-8074-7","article-title":"Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety","volume":"263","author":"Bellante","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0715","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0972-5229.156476","article-title":"Complications during the management of pediatric refractory status epilepticus with benzodiazepine and pentobarbital infusions","volume":"19","author":"Patten","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0720","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0725","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PCC.0000000000000173","article-title":"Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies","volume":"15","author":"Wilkes","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0730","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s13054-018-2235-2","article-title":"Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus","volume":"22","author":"Mad\u017ear","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb0735","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/epi.14706","article-title":"Duration of therapeutic coma and outcome of refractory status epilepticus","volume":"60","author":"Muhlhofer","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0740","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.braindev.2018.08.001","article-title":"Fosphenytoin vs. continuous midazolam for pediatric febrile status epilepticus","volume":"40","author":"Nishiyama","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0745","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus","volume":"17","author":"Singhi","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0750","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus","volume":"82","author":"Fernandez","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0755","first-page":"67","article-title":"Review and update of the Hong Kong epilepsy guideline on status epilepticus","volume":"23","author":"Fung","year":"2017","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.braindev.2024.104306_bb0760","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-3565(25)03582-7","article-title":"Anesthetic properties of sodium 5-allyl-5-(1-methylbutyl)-2-thiobarbiturate and certain other thiobarbiturates in dogs","volume":"95","author":"Wyngaarden","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.braindev.2024.104306_bb0765","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2020.03.012","article-title":"Thiamylal anaesthetic therapy for febrile refractory status epilepticus in children","volume":"80","author":"Ishida","year":"2020","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0770","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.braindev.2017.04.005","article-title":"Therapeutic burst-suppression coma in pediatric febrile refractory status epilepticus","volume":"39","author":"Lin","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0775","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Shorvon","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.braindev.2024.104306_bb0780","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/0972-5229.156484","article-title":"Intravenous ketamine for treatment of super-refractory convulsive status epilepticus with septic shock: a report of two cases","volume":"19","author":"Shrestha","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0785","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","article-title":"Efficacy and safety of ketamine in refractory status epilepticus in children","volume":"79","author":"Rosati","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0790","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.yebeh.2015.07.040","article-title":"Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus","volume":"52","author":"Sabharwal","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0795","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"H\u00f6fler","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.braindev.2024.104306_bb0800","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0805","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1525-5050(02)00643-1","article-title":"Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity","volume":"4","author":"Ubogu","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0810","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eplepsyres.2008.08.005","article-title":"Ketamine successfully terminates malignant status epilepticus","volume":"82","author":"Pr\u00fcss","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106960","article-title":"Secondary hypothermia in patients with super-refractory status epilepticus managed with propofol and ketamine","volume":"105","author":"Sabharwal","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0820","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archneur.61.8.1254","article-title":"Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane","volume":"61","author":"Mirsattari","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0825","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF01541251","article-title":"Isoflurane in the management of status epilepticus after surgery for lesion around the motor area","volume":"116","author":"Sakaki","year":"1992","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.braindev.2024.104306_bb0830","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp.55.8.739","article-title":"Control of epilepsia partialis continua and secondarily generalised status epilepticus with isoflurane","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2024.104306_bb0835","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eplepsyres.2011.09.017","article-title":"The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center","volume":"98","author":"Synowiec","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb0840","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1600-0404.2011.01562.x","article-title":"Oral topiramate as an add-on treatment for refractory status epilepticus","volume":"125","author":"Stojanova","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2024.104306_bb0845","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00381-011-1432-y","article-title":"Treatment of pediatric refractory status epilepticus with topiramate","volume":"27","author":"Akyildiz","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.braindev.2024.104306_bb0850","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1590\/S0004-282X2011000400031","article-title":"Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency","volume":"69","author":"Bragatti","year":"2011","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.braindev.2024.104306_bb0855","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1528-1167.2006.00564.x","article-title":"Topiramate loading for refractory status epilepticus in children","volume":"47","author":"Perry","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0860","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/08830738050200031701","article-title":"Pediatric refractory partial status epilepticus responsive to topiramate","volume":"20","author":"Blumkin","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0865","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.yebeh.2003.07.016","article-title":"Topiramate and status epilepticus: report of three cases","volume":"4","author":"Bensalem","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0870","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1046\/j.1528-1157.2003.11803.x","article-title":"Efficacy of topiramate in children with refractory status epilepticus","volume":"44","author":"Kahriman","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0875","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1468-1331.2002.00304.x","article-title":"Topiramate in drug-resistant complex partial status epilepticus","volume":"9","author":"Reuber","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0880","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.WNL.0000042783.86439.27","article-title":"The use of topiramate in refractory status epilepticus","volume":"60","author":"Towne","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb0885","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12028-010-9501-8","article-title":"The use of lacosamide in refractory status epilepticus","volume":"14","author":"Goodwin","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb0890","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1528-1167.2009.02256.x","article-title":"Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide","volume":"51","author":"Tilz","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0895","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2016.09.004","article-title":"Intravenous lacosamide in seizure emergencies: observations from a hospitalized in-patient adult population","volume":"42","author":"d\u2019Orsi","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb0900","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/j.1528-1167.2010.02646.x","article-title":"Oral pregabalin as an add-on treatment for status epilepticus","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0905","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PCC.0b013e3181a0e1cf","article-title":"Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures","volume":"10","author":"Abend","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0910","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s00415-009-5166-7","article-title":"Intravenous levetiracetam as treatment for status epilepticus","volume":"256","author":"Berning","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0915","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eplepsyres.2009.05.004","article-title":"Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy","volume":"86","author":"Cilio","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb0920","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yebeh.2008.09.028","article-title":"Levetiracetam in children with refractory status epilepticus","volume":"14","author":"Gallentine","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0925","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.2008.145458","article-title":"Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus","volume":"80","author":"M\u00f6ddel","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2024.104306_bb0930","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.2007.130260","article-title":"Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus","volume":"79","author":"Knake","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.braindev.2024.104306_bb0935","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000087385","article-title":"Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes","volume":"54","author":"Rossetti","year":"2005","journal-title":"Eur Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb0940","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.wnf.0000185828.80561.ad","article-title":"Levetiracetam in porphyric status epilepticus: a case report","volume":"28","author":"Zaatreh","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.braindev.2024.104306_bb0945","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.braindev.2014.08.003","article-title":"Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase","volume":"37","author":"Ueda","year":"2015","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb0950","article-title":"Oral perampanel for the treatment of super-refractory status epilepticus","volume":"2019","author":"Rahbani","year":"2019","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.braindev.2024.104306_bb0955","article-title":"Super-refractory status epilepticus treated with high dose perampanel: case series and review of the literature","volume":"2019","author":"Newey","year":"2019","journal-title":"Case Rep Crit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb0960","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/ane.13061","article-title":"Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain","volume":"139","author":"Strzelczyk","year":"2019","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 2","key":"10.1016\/j.braindev.2024.104306_bb0965","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/epi.14492","article-title":"Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: a pilot study","volume":"59","author":"Beretta","year":"2018","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.braindev.2024.104306_bb0970","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/epi.14494","article-title":"Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: a single-center audit of 30 patients","volume":"59","author":"Rohracher","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb0975","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ane.12403","article-title":"Stiripentol for the treatment of super-refractory status epilepticus","volume":"132","author":"Strzelczyk","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2024.104306_bb0980","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/ane.12888","article-title":"Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity","volume":"137","author":"Uchida","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2024.104306_bb0985","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1684\/epd.2015.0778","article-title":"Mega-dose phenobarbital therapy for super-refractory status epilepticus","volume":"17","author":"Byun","year":"2015","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.braindev.2024.104306_bb0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107139","article-title":"Treatment of status epilepticus with zonisamide: a multicenter cohort study of 34 patients and review of literature","volume":"109","author":"Hubert","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2024.104306_bb0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2016.04.003","article-title":"Successful treatment of super-refractory tonic status epilepticus with rufinamide: first clinical report","volume":"39","author":"Thompson","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb1000","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pediatrneurol.2014.01.001","article-title":"Therapeutic plasma exchange for malignant refractory status epilepticus: a case report","volume":"50","author":"Gedik","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1005","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1684\/epd.2014.0702","article-title":"Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier","volume":"16","author":"Hainsworth","year":"2014","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.braindev.2024.104306_bb1010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40263-018-0600-y","article-title":"Intravenous corticosteroids as an adjunctive treatment for refractory and super-refractory status epilepticus: an observational cohort study","volume":"33","author":"Pantazou","year":"2019","journal-title":"CNS Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.braindev.2024.104306_bb1015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/epi.14481","article-title":"Place of neurosteroids in the treatment of status epilepticus","volume":"59","author":"Rossetti","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb1020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/acn3.408","article-title":"First-in-man allopregnanolone use in super-refractory status epilepticus","volume":"4","author":"Vaitkevicius","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000000151","article-title":"Ketogenic diet for adults in super-refractory status epilepticus","volume":"82","author":"Thakur","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2024.104306_bb1040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pediatrneurol.2014.12.008","article-title":"Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient","volume":"52","author":"Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS; CHEESE Study Group","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pedneo.2015.01.010","article-title":"Ketogenic diet as a therapeutic option in super-refractory status epilepticus","volume":"56","author":"Fung","year":"2015","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.braindev.2024.104306_bb1050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0883073813516192","article-title":"The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: challenges in implementation in the pediatric and neonatal intensive care units","volume":"30","author":"Cobo","year":"2015","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1055","doi-asserted-by":"crossref","first-page":"e1431","DOI":"10.1542\/peds.2013-3106","article-title":"Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet","volume":"134","author":"Singh","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2024.104306_bb1060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.seizure.2013.03.007","article-title":"Intravenous initiation and maintenance of ketogenic diet: proof of concept in super-refractory status epilepticus","volume":"22","author":"Strzelczyk","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb1065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.braindev.2018.12.007","article-title":"The ketogenic diet for super-refractory status epilepticus patients in intensive care units","volume":"41","author":"Park","year":"2019","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb1070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12028-016-0312-4","article-title":"A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus","volume":"26","author":"Farias-Moeller","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb1075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fneur.2019.00423","article-title":"Ketogenic diet as a treatment for super-refractory status epilepticus in febrile infection-related epilepsy syndrome","volume":"10","author":"Peng","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2016.07.006","article-title":"Ketogenic diet treatment for pediatric super-refractory status epilepticus","volume":"41","author":"Appavu","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2024.104306_bb1085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2016.12.020","article-title":"Combination of ketogenic diet and stiripentol for super-refractory status epilepticus: a case report","volume":"373","author":"Uchida","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2024.104306_bb1090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebcr.2018.05.002","article-title":"Therapeutic augmentation of ketogenic diet with a sodium-glucose cotransporter 2 inhibitor in a super-refractory status epilepticus patient","volume":"10","author":"Blunck","year":"2018","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.braindev.2024.104306_bb1095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12028-018-0653-2","article-title":"The feasibility, safety and effectiveness of a ketogenic diet for refractory status epilepticus in adults in the intensive care unit","volume":"30","author":"Francis","year":"2019","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb1100","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(08)60837-5","article-title":"Induced hypothermia and fever control for prevention and treatment of neurological injuries","volume":"371","author":"Polderman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2024.104306_bb1105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/CCM.0b013e318206bab2","article-title":"Targeted temperature management in critical care: a report and recommendations from five professional societies","volume":"39","author":"Nunnally","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb1110","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1608193","article-title":"Hypothermia for neuroprotection in convulsive status epilepticus","volume":"375","author":"Legriel","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2024.104306_bb1115","first-page":"277","article-title":"Therapeutic hypothermia for pediatric refractory status epilepticus may ameliorate post-status epilepticus epilepsy","volume":"43","author":"Hsu","year":"2020","journal-title":"Biom J"},{"key":"10.1016\/j.braindev.2024.104306_bb1120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.braindev.2015.09.003","article-title":"Targeted temperature management for acute encephalopathy in a Japanese secondary emergency medical care hospital","volume":"38","author":"Murata","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2024.104306_bb1125","article-title":"Reversible splenial lesion in a patient with new-onset refractory status epilepticus (NORSE)","volume":"18","author":"Mizutani","year":"2019","journal-title":"eNeurol Sci"},{"key":"10.1016\/j.braindev.2024.104306_bb1130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14581\/jer.17017","article-title":"Successful use of therapeutic hypothermia for refractory nonconvulsive status epilepticus","volume":"7","author":"Kim","year":"2017","journal-title":"J Epilepsy Res"},{"key":"10.1016\/j.braindev.2024.104306_bb1135","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.4103\/0366-6999.158378","article-title":"Early hypothermia for refractory status epilepticus","volume":"128","author":"Ren","year":"2015","journal-title":"Chin Med J"},{"key":"10.1016\/j.braindev.2024.104306_bb1140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clineuro.2014.08.032","article-title":"Therapeutic hypothermia for status epilepticus: a report, historical perspective, and review","volume":"126","author":"Bennett","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.braindev.2024.104306_bb1145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fneur.2014.00286","article-title":"Management of super-refractory status epilepticus with isoflurane and hypothermia","volume":"5","author":"Zhumadilov","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1150","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.12331","article-title":"Hypothermia for pediatric refractory status epilepticus","volume":"54","author":"Guilliams","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2024.104306_bb1155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/ther.2012.0013","article-title":"Therapeutic hypothermia for refractory status epilepticus in a child with malignant migrating partial seizures of infancy and SCN1A mutation: a case report","volume":"2","author":"Shein","year":"2012","journal-title":"Ther Hypothermia Temp Manag"},{"key":"10.1016\/j.braindev.2024.104306_bb1160","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejpn.2009.12.001","article-title":"Mild hypothermia for refractory focal status epilepticus in an infant with hemimegalencephaly","volume":"14","author":"Elting","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12028-008-9092-9","article-title":"Hypothermia for refractory status epilepticus","volume":"9","author":"Corry","year":"2008","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb1170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12028-008-9168-6","article-title":"Bowel ischemia: a rare complication of thiopental treatment for status epilepticus","volume":"10","author":"Cereda","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.braindev.2024.104306_bb1175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00003246-198404000-00006","article-title":"Hypothermia and barbiturate coma for refractory status epilepticus","volume":"12","author":"Orlowski","year":"1984","journal-title":"Crit Care Med"},{"key":"10.1016\/j.braindev.2024.104306_bb1180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.pediatrneurol.2012.08.013","article-title":"Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients","volume":"47","author":"Lin JJ, Lin KL, Hsia SH, Wang HS; CHEESE Study Group","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1185","article-title":"Utilising therapeutic hypothermia in the control of non-convulsive status epilepticus in a patient with Creutzfeldt-Jakob encephalopathy","volume":"5","author":"Missert","year":"2012","journal-title":"Br J Med Pract"},{"key":"10.1016\/j.braindev.2024.104306_bb1190","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archneur.1969.00480100106015","article-title":"Inhibition of focal seizures by moderate hypothermia. A clinical and experimental study","volume":"20","author":"Vastola","year":"1969","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2024.104306_bb1195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.braindev.2004.12.005","article-title":"A case of acute encephalitis with refractory, repetitive partial seizures, presenting autoantibody to glutamate receptor Gluepsilon2","volume":"27","author":"Ito","year":"2005","journal-title":"Brain Dev"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:45:22Z","timestamp":1740123922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":239,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0387760424001591"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.104306","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Japanese guidelines for treatment of pediatric status epilepticus \u2013 2023","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.104306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V. CC BY 4.0","name":"copyright","label":"Copyright"}],"article-number":"104306"}}